300583
vs
S
Shanghai Composite
300583
Over the past 12 months, Shandong Sito Bio-technology Co Ltd has underperformed Shanghai Composite, delivering a return of -41% compared to the Shanghai Composite's +23% growth.
Stocks Performance
300583 vs Shanghai Composite
Performance Gap
300583 vs Shanghai Composite
Performance By Year
300583 vs Shanghai Composite
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Shandong Sito Bio-technology Co Ltd
Glance View
Shandong Sito Bio-technology Co., Ltd. provides steroidal pharmaceutical raw materials using biotechnology. The company is headquartered in Heze, Shandong and currently employs 1,140 full-time employees. The company went IPO on 2017-01-06. The firm operates three product segments. The Steroid Raw Materials segment is engaged in the manufacturing of steroid raw materials using genetic engineering technology and microbial transformation technology, such as androstenedione, androstenedione, 9-hydroxyandrostenedione, hydroxyprogesterone and so on. The firm also operates Steroidal Finished Drug segment and Non-Steroidal Finished Drug segment through its subsidiary.
